Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma

INTRODUCTION: Transarterial chemoembolization (TACE) is the first-line treatment for patients with intermediate-stage hepatocellular carcinoma (HCC). For patients without an adequate response, current finding suggests that treatment with molecular target agents, approved for advanced stage, might pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira-Silva, Joel, Costa-Moreira, Pedro, Cardoso, Helder, Liberal, Rodrigo, Pereira, Pedro, Macedo, Guilherme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891150/
https://www.ncbi.nlm.nih.gov/pubmed/36743988
http://dx.doi.org/10.1159/000520530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891150/
https://www.ncbi.nlm.nih.gov/pubmed/36743988
http://dx.doi.org/10.1159/000520530

Ejemplares similares